Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
3 clinical trials · Condition
◉ Watch Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer (NCT04214067) | National Cancer Institute (NCI) | 2020-04-09 |
Track Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.